| Symbol |
Name |
Standardized Value |
|
STK11
|
serine/threonine kinase 11
|
2.528
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.492
|
|
CD34
|
CD34 molecule
|
2.41
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.358
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
2.311
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
2.301
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
2.205
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
2.188
|
|
KDR
|
kinase insert domain receptor
|
2.148
|
|
ALB
|
albumin
|
2.099
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
2.063
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
2.054
|
|
FLT1
|
fms-related tyrosine kinase 1
|
2.035
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
2.021
|
|
DLL4
|
delta-like 4 (Drosophila)
|
2.009
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.997
|
|
ANGPT1
|
angiopoietin 1
|
1.969
|
|
ZNF185
|
zinc finger protein 185 (LIM domain)
|
1.955
|
|
PGF
|
placental growth factor
|
1.953
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.953
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.947
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.947
|
|
ANGPT2
|
angiopoietin 2
|
1.944
|
|
MME
|
membrane metallo-endopeptidase
|
1.922
|
|
EFNB2
|
ephrin-B2
|
1.92
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.865
|
|
VEGFC
|
vascular endothelial growth factor C
|
1.859
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.851
|
|
PRSS57
|
protease, serine, 57
|
1.85
|
|
MRPL58
|
mitochondrial ribosomal protein L58
|
1.807
|
|
VEGFD
|
vascular endothelial growth factor D
|
1.77
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
1.764
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.763
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.759
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.749
|
|
FGF17
|
fibroblast growth factor 17
|
1.737
|
|
FGF7
|
fibroblast growth factor 7
|
1.734
|
|
FGF22
|
fibroblast growth factor 22
|
1.733
|
|
FGF18
|
fibroblast growth factor 18
|
1.733
|
|
VEGFB
|
vascular endothelial growth factor B
|
1.733
|
|
FGF16
|
fibroblast growth factor 16
|
1.731
|
|
FGF6
|
fibroblast growth factor 6
|
1.731
|
|
FGF20
|
fibroblast growth factor 20
|
1.728
|
|
FGF10
|
fibroblast growth factor 10
|
1.724
|
|
FGF9
|
fibroblast growth factor 9
|
1.724
|
|
FGF4
|
fibroblast growth factor 4
|
1.723
|
|
FGF5
|
fibroblast growth factor 5
|
1.723
|
|
F2
|
coagulation factor II (thrombin)
|
1.723
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.718
|
|
FGF3
|
fibroblast growth factor 3
|
1.717
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.708
|
|
KRT7
|
keratin 7, type II
|
1.707
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
1.701
|
|
SMAD4
|
SMAD family member 4
|
1.696
|
|
EPHB4
|
EPH receptor B4
|
1.695
|
|
KRT20
|
keratin 20, type I
|
1.693
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.693
|
|
CD4
|
CD4 molecule
|
1.685
|
|
CD5
|
CD5 molecule
|
1.68
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.679
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.662
|
|
ENG
|
endoglin
|
1.662
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.66
|
|
TNF
|
tumor necrosis factor
|
1.629
|
|
SYP
|
synaptophysin
|
1.628
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
1.625
|
|
CDX2
|
caudal type homeobox 2
|
1.625
|
|
NRP1
|
neuropilin 1
|
1.62
|
|
IL6
|
interleukin 6
|
1.616
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.614
|
|
CHGA
|
chromogranin A
|
1.606
|
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1
|
1.599
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.588
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.579
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.57
|
|
FGF13
|
fibroblast growth factor 13
|
1.567
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.567
|
|
VWF
|
von Willebrand factor
|
1.562
|
|
GCG
|
glucagon
|
1.56
|
|
PLG
|
plasminogen
|
1.552
|
|
PDGFC
|
platelet derived growth factor C
|
1.549
|
|
FN1
|
fibronectin 1
|
1.544
|
|
SST
|
somatostatin
|
1.54
|
|
PTEN
|
phosphatase and tensin homolog
|
1.538
|
|
TP53
|
tumor protein p53
|
1.531
|
|
NF1
|
neurofibromin 1
|
1.518
|
|
CD8A
|
CD8a molecule
|
1.514
|
|
GAST
|
gastrin
|
1.504
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.495
|
|
THBS1
|
thrombospondin 1
|
1.478
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.477
|
|
MUTYH
|
mutY homolog
|
1.47
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.468
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.462
|
|
MSH6
|
mutS homolog 6
|
1.457
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.451
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.45
|
|
MSH2
|
mutS homolog 2
|
1.444
|
|
EPHA1
|
EPH receptor A1
|
1.441
|
|
MLH1
|
mutL homolog 1
|
1.439
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.433
|
|
MMP9
|
matrix metallopeptidase 9
|
1.425
|
|
SDC1
|
syndecan 1
|
1.417
|
|
IL1B
|
interleukin 1, beta
|
1.416
|
|
ANGPT4
|
angiopoietin 4
|
1.413
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.413
|
|
EGF
|
epidermal growth factor
|
1.411
|
|
PDPN
|
podoplanin
|
1.407
|
|
CCND1
|
cyclin D1
|
1.4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.394
|
|
SH2D3A
|
SH2 domain containing 3A
|
1.391
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.385
|
|
NRP2
|
neuropilin 2
|
1.38
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.377
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.373
|
|
JAG1
|
jagged 1
|
1.37
|
|
CALD1
|
caldesmon 1
|
1.364
|
|
IL10
|
interleukin 10
|
1.361
|
|
IFNG
|
interferon, gamma
|
1.358
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
1.354
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
1.348
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.345
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.336
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.324
|
|
TYMP
|
thymidine phosphorylase
|
1.311
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.301
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.299
|
|
PROM1
|
prominin 1
|
1.292
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.29
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.279
|
|
HBG1
|
hemoglobin, gamma A
|
1.277
|
|
PNLIP
|
pancreatic lipase
|
1.276
|
|
AFP
|
alpha-fetoprotein
|
1.275
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.273
|
|
CD19
|
CD19 molecule
|
1.27
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
1.267
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
1.263
|
|
ACE
|
angiotensin I converting enzyme
|
1.262
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
1.257
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.253
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
1.248
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
1.245
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.244
|
|
UNC5B
|
unc-5 homolog B (C. elegans)
|
1.244
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.238
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.236
|
|
TGM2
|
transglutaminase 2
|
1.234
|
|
MMP2
|
matrix metallopeptidase 2
|
1.234
|
|
IL4
|
interleukin 4
|
1.226
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.225
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
1.223
|
|
PROX1
|
prospero homeobox 1
|
1.222
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.222
|
|
EPAS1
|
endothelial PAS domain protein 1
|
1.218
|
|
CD68
|
CD68 molecule
|
1.218
|
|
IL1A
|
interleukin 1, alpha
|
1.216
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.21
|
|
SPN
|
sialophorin
|
1.204
|
|
IFNA13
|
interferon, alpha 13
|
1.204
|
|
VTN
|
vitronectin
|
1.202
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
1.202
|
|
IFNA2
|
interferon, alpha 2
|
1.201
|
|
IFNA1
|
interferon, alpha 1
|
1.199
|
|
IFNA16
|
interferon, alpha 16
|
1.194
|
|
IFNA10
|
interferon, alpha 10
|
1.193
|
|
IFNA14
|
interferon, alpha 14
|
1.193
|
|
IFNA21
|
interferon, alpha 21
|
1.193
|
|
IFNA7
|
interferon, alpha 7
|
1.193
|
|
IFNA8
|
interferon, alpha 8
|
1.193
|
|
IFNA6
|
interferon, alpha 6
|
1.192
|
|
IFNA5
|
interferon, alpha 5
|
1.191
|
|
IFNA17
|
interferon, alpha 17
|
1.191
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.189
|
|
IFNA4
|
interferon, alpha 4
|
1.188
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
1.186
|
|
PXDN
|
peroxidasin
|
1.183
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
1.183
|
|
MEFV
|
Mediterranean fever
|
1.182
|
|
PAX5
|
paired box 5
|
1.182
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
1.178
|
|
PXDNL
|
peroxidasin-like
|
1.177
|
|
ACVRL1
|
activin A receptor type II-like 1
|
1.174
|
|
EGFR
|
epidermal growth factor receptor
|
1.172
|
|
NRARP
|
NOTCH-regulated ankyrin repeat protein
|
1.171
|
|
ACR
|
acrosin
|
1.165
|
|
KNG1
|
kininogen 1
|
1.165
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
1.158
|
|
SELE
|
selectin E
|
1.157
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.157
|
|
RET
|
ret proto-oncogene
|
1.156
|
|
INS
|
insulin
|
1.156
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
1.156
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.155
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
1.146
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.141
|
|
SH2D3C
|
SH2 domain containing 3C
|
1.14
|
|
TJP1
|
tight junction protein 1
|
1.125
|
|
CD38
|
CD38 molecule
|
1.121
|
|
PDGFD
|
platelet derived growth factor D
|
1.116
|
|
EMCN
|
endomucin
|
1.115
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.113
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.11
|
|
NOTCH4
|
notch 4
|
1.106
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.097
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
1.093
|
|
EPHA2
|
EPH receptor A2
|
1.093
|
|
CD274
|
CD274 molecule
|
1.089
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.087
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
1.086
|
|
PLAU
|
plasminogen activator, urokinase
|
1.085
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.08
|
|
CKM
|
creatine kinase, muscle
|
1.08
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.079
|
|
APLNR
|
apelin receptor
|
1.078
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.071
|
|
CALB2
|
calbindin 2
|
1.068
|
|
NOTCH1
|
notch 1
|
1.064
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
1.062
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.061
|
|
TGFA
|
transforming growth factor, alpha
|
1.06
|
|
NTHL1
|
nth endonuclease III-like 1 (E. coli)
|
1.058
|
|
CKB
|
creatine kinase, brain
|
1.054
|
|
MPO
|
myeloperoxidase
|
1.051
|
|
GUCA2B
|
guanylate cyclase activator 2B (uroguanylin)
|
1.051
|
|
TLR4
|
toll-like receptor 4
|
1.049
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.044
|
|
SHH
|
sonic hedgehog
|
1.042
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
1.036
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.034
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.031
|
|
OCLN
|
occludin
|
1.031
|
|
FAM174C
|
family with sequence similarity 174 member C
|
1.03
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.03
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
1.025
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
1.014
|
|
CDC42
|
cell division cycle 42
|
1.012
|
|
POMC
|
proopiomelanocortin
|
1.012
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.009
|
|
EFNA2
|
ephrin-A2
|
1.009
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.008
|
|
KITLG
|
KIT ligand
|
1.005
|
|
EFNA1
|
ephrin-A1
|
1.002
|
|
APLN
|
apelin
|
1.002
|
